These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1460723)

  • 1. Marfan syndrome, hypertrophic cardiomyopathy findings underline avoidance of some sports.
    Goldsmith MF
    JAMA; 1992 Dec 23-30; 268(24):3413-4. PubMed ID: 1460723
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosing the heart of the problem.
    Nat Genet; 1993 Jul; 4(3):211-2. PubMed ID: 8358424
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome.
    Vincent GM
    Heart; 2001 Jul; 86(1):12-4. PubMed ID: 11410552
    [No Abstract]   [Full Text] [Related]  

  • 4. The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome.
    Burn J; Camm J; Davies MJ; Peltonen L; Schwartz PJ; Watkins H
    Heart; 1997 Aug; 78(2):110-6. PubMed ID: 9326982
    [No Abstract]   [Full Text] [Related]  

  • 5. The athlete's heart: prevention of sudden cardiac death.
    Manshadi R
    Rev Cardiovasc Med; 2008; 9(4):259-60. PubMed ID: 19122583
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.
    Maron BJ; Moller JH; Seidman CE; Vincent GM; Dietz HC; Moss AJ; Sondheimer HM; Pyeritz RE; McGee G; Epstein AE
    Circulation; 1998 Oct; 98(14):1460-71. PubMed ID: 9841131
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for hypertrophic cardiomyopathy in young athletes.
    Corrado D; Basso C; Schiavon M; Thiene G
    N Engl J Med; 1998 Aug; 339(6):364-9. PubMed ID: 9691102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AHA assesses the impact of genotyping on diagnosis of genetic cardiac disease. American Heart Association.
    Morey SS
    Am Fam Physician; 1999 May; 59(10):2915-6, 2918. PubMed ID: 10348078
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death.
    Chung WK; Kitner C; Maron BJ
    Cardiol Young; 2011 Jun; 21(3):345-8. PubMed ID: 21262074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of molecular genetics on clinical cardiology.
    Mayosi BM; Watkins H
    J R Coll Physicians Lond; 1999; 33(2):124-31. PubMed ID: 10340258
    [No Abstract]   [Full Text] [Related]  

  • 11. Thick hearts, high stakes, great uncertainties: screening athletes for hypertrophic cardiomyopathy.
    Baggish A; Thompson PD
    Heart; 2009 Mar; 95(5):345-7. PubMed ID: 18977800
    [No Abstract]   [Full Text] [Related]  

  • 12. Syncope and sudden death in the adolescent.
    Walsh CA
    Adolesc Med; 2001 Feb; 12(1):105-32. PubMed ID: 11224026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden unexpected death in sports.
    Rowland TW
    Pediatr Ann; 1992 Mar; 21(3):189, 193-5. PubMed ID: 1608675
    [No Abstract]   [Full Text] [Related]  

  • 14. Marfan syndrome: identification and management.
    Eaton L; Meiner SE
    Medsurg Nurs; 1999 Apr; 8(2):113-7. PubMed ID: 10410009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death in young athletes.
    Basavarajaiah S; Shah A; Sharma S
    Heart; 2007 Mar; 93(3):287-9. PubMed ID: 17322504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular genomics: implications for acute and critical care nurses.
    Quinn Griffin MT; Klein D; Winkelman C
    Dimens Crit Care Nurs; 2013; 32(5):213-21. PubMed ID: 23933638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical Perspectives on Sudden Deaths in Young Athletes With Evolution over 35 Years.
    Maron BJ
    Am J Cardiol; 2015 Nov; 116(9):1461-8. PubMed ID: 26394831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular genetics of cardiovascular diseases].
    Schunkert H; Hense HW
    Dtsch Med Wochenschr; 1995 Apr; 120(15):533-9. PubMed ID: 7720536
    [No Abstract]   [Full Text] [Related]  

  • 19. Sports and Exercise in Athletes with Hypertrophic Cardiomyopathy.
    Alpert C; Day SM; Saberi S
    Clin Sports Med; 2015 Jul; 34(3):489-505. PubMed ID: 26100424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology of heart disease. Synopsis of the pathophysiological basis of cardiac hypertrophy, familial hypertrophic cardiomyopathy, long QT syndrome and Marfan syndrome.
    Kurabayashi M; Yazaki Y
    Intern Med; 1996 Apr; 35(4):243-8. PubMed ID: 8739775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.